Biological activities of drug inactive ingredients

Chenyang Zhang(Macau University of Science and Technology), Jianqing Gao(Zhejiang University), Mingkun Lu(Nanjing Medical University), Fengcheng Li(Zhejiang University), Minjie Mou(Zhejiang University), Ying Zhou(Inner Mongolia Normal University), Xichen Lian(Zhejiang University), Huaicheng Sun(Zhejiang Lab), Zhenyu Zeng(Zhejiang University), Bing Zhang(National Institute for Communicable Disease Control and Prevention), Wei Zhang(Cornell University), Yunxia Wang(University of Kansas Medical Center), Feng Zhu(Zhejiang University), Shuiyang Shi(Second Affiliated Hospital of Zhejiang University), Zhaorong Li(Zhejiang Lab), Yunqing Qiu(Westlake University)
Briefings in Bioinformatics
April 14, 2022
10.1093/bib/bbac160
Cited by 18

Related Papers

Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms
|Gut|2020|1.4k
Mechanisms of drug combinations: interaction and network perspectives
|Nature Reviews Drug Discovery|2009|954
Therapeutic target database 2020: enriched resource for facilitating research and early development of targeted therapeutics
|Nucleic Acids Research|2019|830
Therapeutic target database update 2022: facilitating drug discovery with enriched comparative data of targeted agents
|Nucleic Acids Research|2021|710
Comparative genetic architectures of schizophrenia in East Asian and European populations
|Nature Genetics|2019|709